000 | 01950 a2200505 4500 | ||
---|---|---|---|
005 | 20250515154304.0 | ||
264 | 0 | _c20090720 | |
008 | 200907s 0 0 eng d | ||
022 | _a1078-0432 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-08-1923 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBroniscer, Alberto | |
245 | 0 | 0 |
_aPhase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJan 2009 |
||
300 |
_a701-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnticonvulsants _xpharmacology |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aErlotinib Hydrochloride |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlioma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMaximum Tolerated Dose |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aBaker, Suzanne J | |
700 | 1 | _aStewart, Clinton F | |
700 | 1 | _aMerchant, Thomas E | |
700 | 1 | _aLaningham, Fred H | |
700 | 1 | _aSchaiquevich, Paula | |
700 | 1 | _aKocak, Mehmet | |
700 | 1 | _aMorris, E Brannon | |
700 | 1 | _aEndersby, Raelene | |
700 | 1 | _aEllison, David W | |
700 | 1 | _aGajjar, Amar | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 15 _gno. 2 _gp. 701-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-08-1923 _zAvailable from publisher's website |
999 |
_c18595422 _d18595422 |